DAVID PANIAGUA, M.D.
Osteopathic Medicine at Holcombe Blvd, Houston, TX

License number
Texas K8405
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2002 Holcombe Blvd, Houston, TX 77030
Phone
(713) 794-7300
(713) 794-7492 (Fax)

Personal information

See more information about DAVID PANIAGUA at radaris.com
Name
Address
Phone
David Paniagua, age 63
6801 Rearden Rd, Austin, TX 78745
David Paniagua
4423 Cypress Woods St, San Antonio, TX 78249
David Paniagua, age 61
3813 Drummond St, Houston, TX 77025
(713) 668-2907
David Paniagua, age 64
14419 Twin Elm Woods, San Antonio, TX 78249
(210) 493-1266
David Paniagua
San Antonio, TX
(210) 493-1266

Organization information

See more information about DAVID PANIAGUA at bizstanding.com

Va Hospital - Daniel Musher MD

2002 Holcombe Blvd #128, Houston, TX 77030

Doing business as:
Va Hospital - Kathy U Sam MD<br>Va Hospital - Mathews L George MD<br>Va Hospital<br>Va Hospital - Derek W Meeks MD<br>Va Hospital - David Paniagua MD
Phone:
(713) 791-1414 (Phone), (713) 794-8628 (Phone), (713) 794-7300 (Phone)
Categories:
Infectious Disease Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Hematology Physicians & Surgeons, ...


DAVID PANIAGUA, PA

3813 Drummond St, Houston, TX 77025

Status:
Inactive
Doing business as:
David Paniagua, PA
Registration:
Jan 30, 2009
State ID:
0801081127
Business type:
Professional Association
President , Treasurer , Director , Member , Secretary , Vice-President:
David Paniagua President , Treasurer , Director , Member , Secretary , Vice-President, inactive
TIN:
32038806058


Dr David Paniagua Class A Common

3813 Drummond St, Houston, TX 77025

Status:
Inactive
Governing Person:
Colibri Heart Valve Llc (Governing Person)

Professional information

David Paniagua Photo 1

Medical Director At Endoluminal Technology Research

Position:
Medical director at Endoluminal Technology Research
Location:
Houston, Texas Area
Industry:
Biotechnology
Work:
Endoluminal Technology Research - Medical director
Skills:
Clinical Research, Clinical Trials


David Paniagua Photo 2

David Paniagua, Houston TX

Specialties:
Internal Medicine, Cardiology, Cardiovascular Disease, Interventional Cardiology
Work:
Houston Veterans Affairs Medical Center
2002 Holcombe Blvd, Houston, TX 77030 Southwest Cardiovascular Consultants
6624 Fannin St, Houston, TX 77030
Education:
Universidad De Costa Rica (1986) Cardiovascular Disease


David Paniagua Photo 3

Medical Director At Endoluminal Technology Research

Position:
Medical director at Endoluminal Technology Research
Location:
Houston, Texas Area
Industry:
Biotechnology
Work:
Endoluminal Technology Research - Medical director
Skills:
Clinical Research, Clinical Trials


David Paniagua Photo 4

David Paniagua, Houston TX

Specialties:
Cardiologist
Address:
2002 Holcombe Blvd, Houston, TX 77030
6620 Main St, Houston, TX 77030
6624 Fannin St, Houston, TX 77030
Education:
University of Costa Rica, Faculty of Medicine - Doctor of Medicine
Mount Sinai Medical Center - Fellowship - Cardiology
Mount Sinai Medical Center - Residency - Internal Medicine


David Paniagua Photo 5

Percutaneously Deliverable Heart Valve Including Folded Membrane Cusps With Integral Leaflets

US Patent:
2012018, Jul 19, 2012
Filed:
Dec 14, 2011
Appl. No.:
13/326196
Inventors:
R. David FISH - Houston TX, US
Eduaro INDUNI - Alajuela, CR
David PANIAGUA - Houston TX, US
Assignee:
COLIBRI HEART VALVE LLC - Broomfield CO
International Classification:
A61F 2/24, B31B 1/26
US Classification:
623 213, 493405
Abstract:
A transcatheter, percutaneously implantable, prosthetic heart valve is provided that comprises a lattice frame and two or more integrated cusp and leaflet folded structures attached to the lattice frame. The two or more integrated cusp and leaflet folded structures each comprise a flat sheet of biocompatible membrane that is folded to include a substantially conical shape according to a flat folding pattern. The substantially conical shape is further formed by joining apposing sides of the substantially conical shape along a seam. The two or more integrated cusp and leaflet folded structures are each attached along their respective seams to the lattice frame in a direction substantially parallel to an axis of the lattice frame. Embodiments of valves described herein have application within the entire vascular system.


David Paniagua Photo 6

Percutaneously Deliverable Heart Valve And Methods Associated Therewith

US Patent:
2013012, May 16, 2013
Filed:
Dec 21, 2012
Appl. No.:
13/723541
Inventors:
COLIBRI HEART VALVE LLC - Broomfield CO, US
David PANIAGUA - Houston TX, US
Assignee:
COLIBRI HEART VALVE LLC - Broomfield CO
International Classification:
A61F 2/24
US Classification:
623 211
Abstract:
A prosthetic heart valve implantable by catheter without surgery includes a substantially “dry” membrane or tissue material. In at least one embodiment, the tissue is folded in a dry state to form a tissue leaflet assembly that is then attached to a frame to form an implantable prosthetic heart valve. Alternatively, one or more tissue leaflets are operatively associated with a frame to form an implantable prosthetic heart valve. The implantable prosthetic heart valve is subsequently pre-mounted on an integrated catheter delivery system. The catheter delivery system that includes the implantable prosthetic heart valve is then packaged and transported while the tissue remains dry. The implantable prosthetic heart valve, while remaining substantially dry, can then be implanted into the receiving patient.


David Paniagua Photo 7

Percutaneously Implantable Replacement Heart Valve Device And Method Of Making Same

US Patent:
8308797, Nov 13, 2012
Filed:
Jul 10, 2004
Appl. No.:
10/887688
Inventors:
David Paniagua - Houston TX, US
Eduardo Induni - Alajuela, CR
Carlos Mejia - Houston TX, US
Francisco Lopez-Jimenez - Rochester MN, US
R. David Fish - Houston TX, US
Assignee:
Colibri Heart Valve, LLC - Broomfield CO
International Classification:
A61F 2/24
US Classification:
623 214
Abstract:
The present invention comprises a percutaneously implantable replacement heart valve device and a method of making same. The replacement heart valve device comprises a stent member made of stainless steel or self-expanding nitinol, a biological tissue artificial valve means disposed within the inner space of the stent member. An implantation and delivery system having a central part which consists of a flexible hollow tube catheter that allows a metallic wire guide to be advanced inside it. The endovascular stented-valve is a glutaraldehyde fixed bovine pericardium which has two or three cusps that open distally to permit unidirectional blood flow. The present invention also comprises a novel method of making a replacement heart valve by taking a rectangular fragment of bovine pericardium treating, drying, folding and rehydrating it in such a way that forms a two- or three-leaflet/cusp valve with the leaflets/cusps formed by folding, thereby eliminating the extent of suturing required, providing improved durability and function.


David Paniagua Photo 8

Percutaneously Deliverable Heart Valve And Methods Associated Therewith

US Patent:
8361144, Jan 29, 2013
Filed:
Mar 1, 2011
Appl. No.:
13/038361
Inventors:
R. David Fish - Houston TX, US
David Paniagua - Houston TX, US
Assignee:
Colibri Heart Valve LLC - Broomfield CO
International Classification:
A61F 2/24
US Classification:
623 211, 623 21, 623 213, 623 217, 435 11
Abstract:
A prosthetic heart valve implantable by catheter without surgery includes a substantially “dry” membrane or tissue material. In at least one embodiment, the tissue is folded in a dry state to form a tissue leaflet assembly that is then attached to a frame to form an implantable prosthetic heart valve. Alternatively, one or more tissue leaflets are operatively associated with a frame to form an implantable prosthetic heart valve. The implantable prosthetic heart valve is subsequently pre-mounted on an integrated catheter delivery system. The catheter delivery system that includes the implantable prosthetic heart valve is then packaged and transported while the tissue remains dry. The implantable prosthetic heart valve, while remaining substantially dry, can then be implanted into the receiving patient.


David Paniagua Photo 9

Tissue For Prosthetic Implants And Grafts, And Methods Associated Therewith

US Patent:
2011030, Dec 8, 2011
Filed:
Mar 1, 2011
Appl. No.:
13/038260
Inventors:
David PANIAGUA - Houston TX, US
R. David Fish - Houston TX, US
Assignee:
VELA BIOSYSTEMS LLC - Broomfield CO
International Classification:
C12N 5/071
US Classification:
435325
Abstract:
A prepared tissue for medical use with a patient is provided. Methods for preparing such tissue are also provided. Implantable tissue is provided by harvesting a tissue, such as but not limited to a pericardium tissue, and exposing the tissue to various cleaning, rinsing, treatment, separating, and fixation steps. The tissue of at least one embodiment is cleaned with distilled water, rinsed with isopropyl alcohol, and treated with a glutaraldehyde solution. The prepared tissue may be allowed to dry or partially hydrated prior to packaging and shipment. As such, the tissue can be implanted into the receiving patient in either a dry or wet state. The relatively thin yet strong tissue material is adapted for implanting within or grafting to human tissue. By way of example, the tissue may be used in a shunt, a valve, as graft material, as a patch, as a prosthetic tissue in a tendon and/or ligament, and a tissue product for wound management.


David Paniagua Photo 10

Percutaneously Implantable Replacement Heart Valve Device And Method Of Making Same

US Patent:
2012031, Dec 6, 2012
Filed:
Feb 6, 2012
Appl. No.:
13/367252
Inventors:
David PANIAGUA - Houston TX, US
Eduardo INDUNI - Alajuela, CR
R. David FISH - Houston TX, US
Assignee:
COLIBRI HEART VALVE LLC - Broomfield CO
International Classification:
A61F 2/24
US Classification:
600 36
Abstract:
A method of making a replacement heart valve device whereby a fragment of biocompatible tissue material is treated and soaked in one or more alcohol solutions and a solution of glutaraldehyde. The dried biocompatible tissue material is folded and rehydrated in such a way that forms a two- or three-leaflet/cusp valve without affixing of separate cusps or leaflets or cutting slits into the biocompatible tissue material to form the cusps or leaflets. After the biocompatible tissue material is folded, it is affixed at one or more points on the outer surface to the inner cavity or a stent.